MEDIROM Healthcare Group Inc (MRM): Fair Value Consensus

MEDIROM (MRM) revenues are based on attendance at Japanese relaxation centers and the sale of health monitoring gadgets, with the indicator standing at 4.98. Its leadership status in the wellness niche and customer trust allow the company to maintain pricing power. Serving as the primary valuation tool, this price chart confirms the effectiveness of conservative management and the high quality of operational control by the Japanese management.

This indicator reflects the weighted average expectation of professional analysts regarding the asset's fair value, measuring market growth potential through the aggregation of target prices. The trend in the consensus valuation confirms the investment attractiveness of MEDIROM (MRM), whose resilience to global logistical disruptions is ensured by the exclusive use of local consumables suppliers in Japan.